AVROBIO, Inc.·4

Feb 4, 5:18 PM ET

Ostrowski Erik 4

4 · AVROBIO, Inc. · Filed Feb 4, 2022

Insider Transaction Report

Form 4
Period: 2022-02-02
Ostrowski Erik
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-02+170,000170,000 total
    Exercise: $1.84Exp: 2032-02-01Common Stock (170,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-02-02+145,000145,000 total
    Exercise: $1.84Exp: 2032-02-01Common Stock (145,000 underlying)
Footnotes (1)
  • [F1]25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT